Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)

Madrigal Pharmaceuticals (MDGL) sees a surge in social media buzz around potential acquisition targets and positive clinical trial results for Rezdiffra. Investors are discussing the stock as undervalued amidst profit-taking pressures.

About Madrigal Pharmaceuticals, Inc. Common Stock

Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is a biopharmaceutical company focused on therapeutics for non-alcoholic steatohepatitis (NASH).
Madrigal Pharmaceuticals, Inc. Common Stock uses the ticker $MDGL for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) social dominance is up 666.67% from the previous week.
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) creators is up 55.46% from the previous week.
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) engagements is up 141.36% from the previous week.
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) mentions is up 55.82% from the previous week.
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) posts created is up 82.61% from the previous week.

Price: $464.70

Price 24-Hour Time-Series Raw Data
The stock price has experienced a slight decline due to profit-taking after a surge from acquisition rumors and positive clinical trial results, with analyst target raises not fully offsetting selling pressure.

24-Hour: -2.02% 7-Day: -2.26% 30-Day: -7.37%

1-Year High: $602.80 on 2025-12-22
1-Year Low: $267.30 on 2025-05-24

AltRank: [---]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is currently AltRank #669 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [-----] +347
[--] Month: [-----] +822
[--] Months: [-----] +1,086
[--] Year: [-----] +541
1-Year High: [-----] on 2025-04-19
1-Year Low: [--] on 2025-05-03

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-11-04
1-Year Low: [--] on 2026-02-05

Engagements: [-----] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [------] +141%
[--] Month: [-------] -51%
[--] Months: [---------] -32%
[--] Year: [---------] +6.40%
1-Year High: [-------] on 2025-08-18
1-Year Low: [-----] on 2026-02-08

Engagements by network (24h): News: [--] X: [-----] Reddit: [--] YouTube: [--]

Mentions: [---] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] +56%
[--] Month: [---] +10%
[--] Months: [-----] -35%
[--] Year: [------] +36%
1-Year High: [-----] on 2025-07-17
1-Year Low: [--] on 2025-12-07

Mentions by network (24h): News: [--] X: [---] Reddit: [--] YouTube: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) in the last [--] hours which is down 36% from [---] in the previous [--] hours Daily Average: [--]
[--] Week: [---] +55%
[--] Month: [---] +27%
[--] Months: [-----] -46%
[--] Year: [-----] +68%
1-Year High: [---] on 2025-07-17
1-Year Low: [--] on 2026-02-12

The most influential creators that mention Madrigal Pharmaceuticals, Inc. Common Stock in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@BioStocks	[--]	[------]	[--]	[-----]
@doepke_michel	[--]	[-----]	[--]	[---]
@RyshabTalks	[--]	[-----]	[--]	[---]
@Pharmdca	[--]	[-------]	[--]	[---]
@Andre_AGTC	[--]	[-----]	[--]	[---]
@SnackBioTech	[--]	[-----]	[--]	[---]
@SeanValenc89161	[--]	[---]	[--]	[---]
@Jamce1182025	[--]	[--]	[--]	[--]
@Chartfest1	[--]	[-----]	[--]	[--]
@JoseRestonVA	[--]	[-----]	[--]	[--]

Sentiment: 63%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 63%
Daily Average: 79%
[--] Week: 50% -50%
[--] Month: 57% -14%
[--] Months: 57% -32%
[--] Year: 57% -19%
1-Year High: 98% on 2025-07-17
1-Year Low: 38% on 2025-12-06

Most Supportive Themes:

Acquisition Target: (45%) Madrigal Pharmaceuticals is viewed as a potential acquisition by larger pharmaceutical companies.
Positive Clinical Trial Results: (30%) Recent positive trial results for Rezdiffra and Madrigal's market leadership in MASH are highlighted.
Undervalued Stock: (20%) Many investors believe MDGL is undervalued, presenting a strong buying opportunity.

Most Critical Themes:

Profit-Taking and Market Manipulation: (5%) The recent price decline is attributed to profit-taking and potential market manipulation.

Social Dominance: 0.012%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.012%
Daily Average: 0.026%
[--] Week: 0.012% +0.01%
[--] Month: 0.027% +0.014%
[--] Months: 0.027% -0.035%
[--] Year: 0.027% +0.0022%
1-Year High: 0.145% on 2025-07-17
1-Year Low: 0.0046% on 2026-02-12

Market Dominance: 0.012%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.012%
Daily Average: 0%
1-Year High: 0.265% on 2025-03-25
1-Year Low: 0.00827% on 2025-06-25

Market Cap: $10,554,223,988

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $10,554,223,988
Daily Average: $9,025,792,130
[--] Week: $10,349,366,980 -5.80%
[--] Month: $10,554,223,988 -7.40%
[--] Months: $10,554,223,988 +21%
[--] Year: $10,554,223,988 +44%
1-Year High: $13,691,125,319 on 2025-12-22
1-Year Low: $5,940,710,132 on 2025-05-23

Top Madrigal Pharmaceuticals, Inc. Common Stock Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"Sort of hard to beat the ludicrous amounts given for PD1xVEGFs that probably fail to beat PD1 🤣 China biotech licensing boom to hit record in [----] - with global drugmakers including $NVS $MRK $ABBV and $GSK inking major agreements. $AZN $MDGL https://t.co/tq1h6Tg2mE China biotech licensing boom to hit record in [----] - with global drugmakers including $NVS $MRK $ABBV and $GSK inking major agreements. $AZN $MDGL https://t.co/tq1h6Tg2mE"
X Link @Archimedes20311 2026-02-15T15:17Z [---] followers, [---] engagements

"China biotech licensing boom to hit record in [----] - with global drugmakers including $NVS $MRK $ABBV and $GSK inking major agreements. $AZN $MDGL https://ca.finance.yahoo.com/news/analysis-china-biotech-licensing-boom-093217672.html https://ca.finance.yahoo.com/news/analysis-china-biotech-licensing-boom-093217672.html"
X Link @BioStocks 2026-02-15T14:26Z 71.4K followers, [----] engagements

"China biotech licensing boom to hit record in [----] as pipeline swells. $MDGL $MRK $GSK $BNTX $SMMT $VSTM $PFE $AZN $NVS $RHHBY https://www.reuters.com/sustainability/climate-energy/china-biotech-licensing-boom-hit-record-2026-pipeline-swells-2026-02-13/ https://www.reuters.com/sustainability/climate-energy/china-biotech-licensing-boom-hit-record-2026-pipeline-swells-2026-02-13/"
X Link @doepke_michel 2026-02-15T10:08Z [----] followers, [----] engagements

"Some implied moves for earnings next week - [---] companies reporting(2of2): $OLED 8.7% $COCO 11.7% $SEDG 15.6% $MDT 4.9% $BKNG 7.1% $CAR 10.0% $SO 3.3% $ETSY 11.9% $INSM 9.9% $MDGL 8.9% $TZOO 14.9% $FLR 10.1% $TOL 6.0% $MKSI 9.3% $FVRR 11.7% $BLCO 7.5% $PODD 9.0% $WING 13.1% $GPN 9.2% $OXY 4.5% $NTR 4.9% $CAKE 7.2% $CF 4.7% $HLF 14.6% $TAP 6.4% $BHC 5.0% https://www.optionmillionaires.com/some-implied-moves-for-earnings-next-wee-feb-17th-feb-20th-375-companies-reporting/ https://www.optionmillionaires.com/some-implied-moves-for-earnings-next-wee-feb-17th-feb-20th-375-companies-reporting/"
X Link @OMillionaires 2026-02-14T14:48Z 143.2K followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing